Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Cabral, WA; Chernoff, EJ; Marini, JC
   G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha 1(I) chain and alters folding of the N-terminal end of the helix
   MOLECULAR GENETICS AND METABOLISM
   
   W.A. Cabral et al., "G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha 1(I) chain and alters folding of the N-terminal end of the helix", MOL GEN MET, 72(4), 2001, pp. 326-335
2. Marini, JC
   Genetic risk factors for lumbar disk disease
   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
   
   J.C. Marini, "Genetic risk factors for lumbar disk disease", J AM MED A, 285(14), 2001, pp. 1886-1888
3. Bouma, P; Cabral, WA; Cole, WG; Marini, JC
   COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   P. Bouma et al., "COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II", J BIOL CHEM, 276(16), 2001, pp. 13356-13364
4. Forlino, A; Marini, JC
   Osteogenesis imperfecta: Prospects for molecular therapeutics
   MOLECULAR GENETICS AND METABOLISM
   
   A. Forlino e J.C. Marini, "Osteogenesis imperfecta: Prospects for molecular therapeutics", MOL GEN MET, 71(1-2), 2000, pp. 225-232
5. Dawson, PA; Marini, JC
   Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts
   NUCLEIC ACIDS RESEARCH
   
   P.A. Dawson e J.C. Marini, "Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts", NUCL ACID R, 28(20), 2000, pp. 4013-4020
6. Vieira, NE; Goans, RE; Weiss, GH; Hopkins, E; Marini, JC; Yergey, AL
   Calcium kinetics in children with osteogenesis imperfecta type III and IV:Pre- and post-growth hormone therapy
   CALCIFIED TISSUE INTERNATIONAL
   
   N.E. Vieira et al., "Calcium kinetics in children with osteogenesis imperfecta type III and IV:Pre- and post-growth hormone therapy", CALCIF TIS, 67(2), 2000, pp. 97-100
7. Dawson, PA; Marini, JC
   Osteogenesis imperfecta
   GENETICS OF OSTEOPOROSIS AND METABOLIC BONE DISEASE
   
   P.A. Dawson e J.C. Marini, "Osteogenesis imperfecta", GENETICS OF OSTEOPOROSIS AND METABOLIC BONE DISEASE, 2000, pp. 75-93
8. Vieira, NE; Marini, JC; Hopkins, E; Abrams, SA; Yergey, AL
   Effect of growth hormone treatment on calcium kinetics in patients with osteogenesis imperfecta type III and IV
   BONE
   
   N.E. Vieira et al., "Effect of growth hormone treatment on calcium kinetics in patients with osteogenesis imperfecta type III and IV", BONE, 25(4), 1999, pp. 501-505
9. Walker, LC; Marini, JC; Grange, DK; Filie, J; Yeowell, HN
   A patient with Ehlers-Danlos syndrome type VI is homozygous for a premature termination codon in exon 14 of the lysyl hydroxylase 1 gene
   MOLECULAR GENETICS AND METABOLISM
   
   L.C. Walker et al., "A patient with Ehlers-Danlos syndrome type VI is homozygous for a premature termination codon in exon 14 of the lysyl hydroxylase 1 gene", MOL GEN MET, 67(1), 1999, pp. 74-82
10. O'Connell, AC; Marini, JC
    Evaluation of oral problems in an osteogenesis imperfecta population
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    
    A.C. O'Connell e J.C. Marini, "Evaluation of oral problems in an osteogenesis imperfecta population", ORAL SURG O, 87(2), 1999, pp. 189-196
11. Marini, JC
    Osteogenesis imperfecta calls for caution
    NATURE MEDICINE
    
    J.C. Marini, "Osteogenesis imperfecta calls for caution", NAT MED, 5(5), 1999, pp. 466-466
12. Dawson, PA; Kelly, TE; Marini, JC
    Extension of phenotype associated with structural mutations in type T collagen: Siblings with juvenile osteoporosis have an alpha 2(I)Gly436 -> Arg substitution
    JOURNAL OF BONE AND MINERAL RESEARCH
    
    P.A. Dawson et al., "Extension of phenotype associated with structural mutations in type T collagen: Siblings with juvenile osteoporosis have an alpha 2(I)Gly436 -> Arg substitution", J BONE MIN, 14(3), 1999, pp. 449-455
13. Forlino, A; Porter, FD; Lee, EJ; Westphal, H; Marini, JC
    Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha 1(I) G349C substitution - Variability in phenotype in BrtlIV mice
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    A. Forlino et al., "Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha 1(I) G349C substitution - Variability in phenotype in BrtlIV mice", J BIOL CHEM, 274(53), 1999, pp. 37923-37931
14. SARAFOVA AP; CHOI H; FORLINO A; GAJKO A; CABRAL WA; TOSI L; REING CM; MARINI JC
    3 NOVEL TYPE-I COLLAGEN MUTATIONS IN OSTEOGENESIS IMPERFECTA TYPE-IV PROBANDS ARE ASSOCIATED WITH DISCREPANCIES BETWEEN ELECTROPHORETIC MIGRATION OF OSTEOBLAST AND FIBROBLAST COLLAGEN
    Human mutation
    
    A.P. Sarafova et al., "3 NOVEL TYPE-I COLLAGEN MUTATIONS IN OSTEOGENESIS IMPERFECTA TYPE-IV PROBANDS ARE ASSOCIATED WITH DISCREPANCIES BETWEEN ELECTROPHORETIC MIGRATION OF OSTEOBLAST AND FIBROBLAST COLLAGEN", Human mutation, 11(5), 1998, pp. 395-403
15. CABRAL WA; MARINI JC
    OSTEOBLASTS FROM 3 OI PROBANDS PERMIT GREATER INTRACELLULAR SURVIVAL AND SECRETION OF MUTANT COLLAGEN THAN DO FIBROBLASTS
    Molecular biology of the cell
    
    W.A. Cabral e J.C. Marini, "OSTEOBLASTS FROM 3 OI PROBANDS PERMIT GREATER INTRACELLULAR SURVIVAL AND SECRETION OF MUTANT COLLAGEN THAN DO FIBROBLASTS", Molecular biology of the cell, 9, 1998, pp. 336-336
16. FORLINO A; CABRAL WA; MARINI JC
    MUTANT COLLAGEN-SYNTHESIS, MATRIX INCORPORATION AND RETENTION BY CULTURED FIBROBLASTS AND OSTEOBLASTS FROM 2 OI TYPE-IV PROBANDS
    Molecular biology of the cell
    
    A. Forlino et al., "MUTANT COLLAGEN-SYNTHESIS, MATRIX INCORPORATION AND RETENTION BY CULTURED FIBROBLASTS AND OSTEOBLASTS FROM 2 OI TYPE-IV PROBANDS", Molecular biology of the cell, 9, 1998, pp. 337-337
17. FORLINO A; PORTER FD; MARINI JC
    OSTEOGENESIS IMPERFECTA MURINE MODELS - USE OF THE CRE LOX RECOMBINATION SYSTEM TO CREATE THE FIRST KNOCK-IN OI MOUSE/
    European journal of human genetics
    
    A. Forlino et al., "OSTEOGENESIS IMPERFECTA MURINE MODELS - USE OF THE CRE LOX RECOMBINATION SYSTEM TO CREATE THE FIRST KNOCK-IN OI MOUSE/", European journal of human genetics, 6, 1998, pp. 803-803
18. DAWSON PA; MARINI JC
    RIBOZYME SUPPRESSION OF MUTANT TYPE-T COLLAGEN MESSENGER-RNA IN CULTURED OI FIBROBLASTS - DEVELOPMENT OF GENE-THERAPY FOR DOMINANT DISORDERS
    Matrix biology
    
    P.A. Dawson e J.C. Marini, "RIBOZYME SUPPRESSION OF MUTANT TYPE-T COLLAGEN MESSENGER-RNA IN CULTURED OI FIBROBLASTS - DEVELOPMENT OF GENE-THERAPY FOR DOMINANT DISORDERS", Matrix biology, 17(2), 1998, pp. 158-158
19. FORLINO A; PORTER FD; MARINI JC
    USE OF THE CRE LOX RECOMBINATION SYSTEM TO CREATE THE FIRST KNOCK-IN MURINE MODEL FOR OSTEOGENESIS IMPERFECTA/
    Matrix biology
    
    A. Forlino et al., "USE OF THE CRE LOX RECOMBINATION SYSTEM TO CREATE THE FIRST KNOCK-IN MURINE MODEL FOR OSTEOGENESIS IMPERFECTA/", Matrix biology, 17(2), 1998, pp. 164-164
20. Forlino, A; Keene, DR; Schmidt, K; Marini, JC
    An alpha 2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of Osteogenesis Imperfecta
    MATRIX BIOLOGY
    
    A. Forlino et al., "An alpha 2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of Osteogenesis Imperfecta", MATRIX BIOL, 17(8-9), 1998, pp. 575-584
21. VIEIRA NE; GOANS RE; WEISS GH; MARINI JC; HOPKINS E; YERGEY AL
    CALCIUM KINETICS IN CHILDREN WITH OSTEOGENESIS-IMPERFECTA TYPE-III AND TYPE-IV - PREGROWTH AND POSTGROWTH HORMONE-THERAPY
    The FASEB journal
    
    N.E. Vieira et al., "CALCIUM KINETICS IN CHILDREN WITH OSTEOGENESIS-IMPERFECTA TYPE-III AND TYPE-IV - PREGROWTH AND POSTGROWTH HORMONE-THERAPY", The FASEB journal, 12(4), 1998, pp. 3174-3174
22. MARINI JC
    OSTEOGENESIS IMPERFECTA - MANAGING BRITTLE BONES
    The New England journal of medicine
    
    J.C. Marini, "OSTEOGENESIS IMPERFECTA - MANAGING BRITTLE BONES", The New England journal of medicine, 339(14), 1998, pp. 986-987
23. BUTTERFIELD RJ; SUDWEEKS JD; BLANKENHORN EP; KORNGOLD R; MARINI JC; TODD JA; ROPER RJ; TEUSCHER C
    NEW GENETIC-LOCI THAT CONTROL SUSCEPTIBILITY AND SYMPTOMS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN INBRED MICE
    The Journal of immunology (1950)
    
    R.J. Butterfield et al., "NEW GENETIC-LOCI THAT CONTROL SUSCEPTIBILITY AND SYMPTOMS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN INBRED MICE", The Journal of immunology (1950), 161(4), 1998, pp. 1860-1867
24. FORLINO A; DAMATO E; VALLI M; CAMERA G; HOPKINS E; MARINI JC; CETTA G; COVIELLO DA
    PHENOTYPIC COMPARISON OF AN OSTEOGENESIS IMPERFECTA TYPE-IV PROBAND WITH A DE-NOVO ALPHA-2(I) GLY922-]SER SUBSTITUTION IN TYPE-I COLLAGEN AND AN UNRELATED PATIENT WITH AN IDENTICAL MUTATION
    Biochemical and molecular medicine
    
    A. Forlino et al., "PHENOTYPIC COMPARISON OF AN OSTEOGENESIS IMPERFECTA TYPE-IV PROBAND WITH A DE-NOVO ALPHA-2(I) GLY922-]SER SUBSTITUTION IN TYPE-I COLLAGEN AND AN UNRELATED PATIENT WITH AN IDENTICAL MUTATION", Biochemical and molecular medicine, 62(1), 1997, pp. 26-35
25. FORLINO A; CABRAL WA; MARINI JC
    SYNTHESIS, SECRETION AND EXTRACELLULAR-MATRIX ANALYSIS OF MUTANT TYPE-I COLLAGEN PRODUCED BY CULTURED OSTEOBLASTS AND FIBROBLASTS FROM 2 TYPE-IV OI PROBANDS
    Molecular biology of the cell
    
    A. Forlino et al., "SYNTHESIS, SECRETION AND EXTRACELLULAR-MATRIX ANALYSIS OF MUTANT TYPE-I COLLAGEN PRODUCED BY CULTURED OSTEOBLASTS AND FIBROBLASTS FROM 2 TYPE-IV OI PROBANDS", Molecular biology of the cell, 8, 1997, pp. 1629-1629
26. VIEIRA NE; MARINI JC; HOPKINS E; YERGEY AL
    EFFECT OF GROWTH-HORMONE (GH) TREATMENT ON CALCIUM KINETICS IN PATIENTS WITH OSTEOGENESIS IMPERFECTA (OI) TYPE-III AND TYPE-IV
    The FASEB journal
    
    N.E. Vieira et al., "EFFECT OF GROWTH-HORMONE (GH) TREATMENT ON CALCIUM KINETICS IN PATIENTS WITH OSTEOGENESIS IMPERFECTA (OI) TYPE-III AND TYPE-IV", The FASEB journal, 11(3), 1997, pp. 2366-2366
27. FORLINO A; CABRAL WA; MARINI JC
    EXPRESSION, SECRETION, AND MATRIX INCORPORATION OF MUTANT TYPE-I COLLAGEN SYNTHESIZED BY CULTURED OI OSTEOBLASTS
    Journal of bone and mineral research
    
    A. Forlino et al., "EXPRESSION, SECRETION, AND MATRIX INCORPORATION OF MUTANT TYPE-I COLLAGEN SYNTHESIZED BY CULTURED OI OSTEOBLASTS", Journal of bone and mineral research, 12, 1997, pp. 527-527
28. MARINI JC; CHROUSUS G; HOPKINS E; REING CM; GLORIEUX FH; GUNDBERG CM
    GROWTH-HORMONE TREATMENT TRIAL OF CHILDREN WITH TYPE-III AND TYPE-IV OSTEOGENESIS IMPERFECTA
    Journal of bone and mineral research
    
    J.C. Marini et al., "GROWTH-HORMONE TREATMENT TRIAL OF CHILDREN WITH TYPE-III AND TYPE-IV OSTEOGENESIS IMPERFECTA", Journal of bone and mineral research, 12, 1997, pp. 527-527
29. GRASSI G; FORLINO A; MARINI JC
    CLEAVAGE OF COLLAGEN RNA TRANSCRIPTS BY HAMMERHEAD RIBOZYMES IN-VITROIS MUTATION-SPECIFIC AND SHOWS COMPETITIVE-BINDING EFFECTS
    Nucleic acids research
    
    G. Grassi et al., "CLEAVAGE OF COLLAGEN RNA TRANSCRIPTS BY HAMMERHEAD RIBOZYMES IN-VITROIS MUTATION-SPECIFIC AND SHOWS COMPETITIVE-BINDING EFFECTS", Nucleic acids research, 25(17), 1997, pp. 3451-3458
30. MARINI JC; GERBER NL
    OSTEOGENESIS IMPERFECTA REHABILITATION AND PROSPECTS FOR GENE-THERAPY
    JAMA, the journal of the American Medical Association
    
    J.C. Marini e N.L. Gerber, "OSTEOGENESIS IMPERFECTA REHABILITATION AND PROSPECTS FOR GENE-THERAPY", JAMA, the journal of the American Medical Association, 277(9), 1997, pp. 746-750
31. HOOPER DC; BAGASRA O; MARINI JC; ZBOREK A; OHNISHI ST; KEAN R; CHAMPION JM; SARKER AB; BOBROSKI L; FARBER JL; AKAIKE T; MAEDA H; KOPROWSKI H
    PREVENTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY TARGETING NITRIC-OXIDE AND PEROXYNITRITE - IMPLICATIONS FOR THE TREATMENT OF MULTIPLE-SCLEROSIS
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    D.C. Hooper et al., "PREVENTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY TARGETING NITRIC-OXIDE AND PEROXYNITRITE - IMPLICATIONS FOR THE TREATMENT OF MULTIPLE-SCLEROSIS", Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2528-2533
32. HORWITZ EM; PROCKOP DJ; MARINI JC; FITZPATRICK LA; GORDON P; KOO W; NEEL M; ORCHARD P; BRENNER MK
    BONE-MARROW TRANSPLANTATION (BMT) TO CORRECT THE MESENCHYMAL DEFECT OF CHILDREN WITH OSTEOGENESIS IMPERFECTA
    Blood
    
    E.M. Horwitz et al., "BONE-MARROW TRANSPLANTATION (BMT) TO CORRECT THE MESENCHYMAL DEFECT OF CHILDREN WITH OSTEOGENESIS IMPERFECTA", Blood, 90(10), 1997, pp. 1014-1014
33. CHARNAS LR; HOPKINS E; MARINI JC
    THE DYNAMIC DEFORMATION SEQUENCE OF BASILAR INVAGINATION IN OSTEOGENESIS IMPERFECTA
    American journal of human genetics
    
    L.R. Charnas et al., "THE DYNAMIC DEFORMATION SEQUENCE OF BASILAR INVAGINATION IN OSTEOGENESIS IMPERFECTA", American journal of human genetics, 61(4), 1997, pp. 519-519
34. FORLINO A; PORTER FD; MARINI JC
    CRE-MEDIATED SITE-SPECIFIC RECOMBINATION IN THE MURINE COL1A1 GENE - GENERATION OF A CONDITIONAL MURINE MODEL FOR OSTEOGENESIS IMPERFECTA
    American journal of human genetics
    
    A. Forlino et al., "CRE-MEDIATED SITE-SPECIFIC RECOMBINATION IN THE MURINE COL1A1 GENE - GENERATION OF A CONDITIONAL MURINE MODEL FOR OSTEOGENESIS IMPERFECTA", American journal of human genetics, 61(4), 1997, pp. 1456-1456
35. KELLY TE; DAWSON PA; MARINI JC
    EXTENSION OF PHENOTYPE ASSOCIATED WITH STRUCTURAL MUTATIONS IN TYPE-ICOLLAGEN - SIBLINGS WITH JUVENILE OSTEOPOROSIS HAVE AN ALPHA-2(I)GLY436-]ARG SUBSTITUTION
    American journal of human genetics
    
    T.E. Kelly et al., "EXTENSION OF PHENOTYPE ASSOCIATED WITH STRUCTURAL MUTATIONS IN TYPE-ICOLLAGEN - SIBLINGS WITH JUVENILE OSTEOPOROSIS HAVE AN ALPHA-2(I)GLY436-]ARG SUBSTITUTION", American journal of human genetics, 61(4), 1997, pp. 1971-1971
36. MARINI JC; FORLINO A; CABRAL WA
    METABOLISM OF MUTANT TYPE-I COLLAGEN DIFFERS IN OSTEOBLASTS AND FIBROBLASTS FROM 2 TYPE-IV O1 PROBANDS
    American journal of human genetics
    
    J.C. Marini et al., "METABOLISM OF MUTANT TYPE-I COLLAGEN DIFFERS IN OSTEOBLASTS AND FIBROBLASTS FROM 2 TYPE-IV O1 PROBANDS", American journal of human genetics, 61(4), 1997, pp. 1986-1986
37. DAWSON PA; GRASSI G; MARINI JC
    SUPPRESSION OF MUTANT TYPE-I COLLAGEN MESSENGER-RNA BY HAMMERHEAD RIBOZYMES IN CULTURED SKIN FIBROBLASTS
    American journal of human genetics
    
    P.A. Dawson et al., "SUPPRESSION OF MUTANT TYPE-I COLLAGEN MESSENGER-RNA BY HAMMERHEAD RIBOZYMES IN CULTURED SKIN FIBROBLASTS", American journal of human genetics, 61(4), 1997, pp. 2076-2076
38. HOPKINS E; CHROUSOS GP; GLORIEUX FH; REING CM; GUNDBERG CM; MARINI JC
    GROWTH-HORMONE TREATMENT TRIAL OF CHILDREN WITH TYPE-III AND TYPE-IV OSTEOGENESIS IMPERFECTA
    American journal of human genetics
    
    E. Hopkins et al., "GROWTH-HORMONE TREATMENT TRIAL OF CHILDREN WITH TYPE-III AND TYPE-IV OSTEOGENESIS IMPERFECTA", American journal of human genetics, 61(4), 1997, pp. 2084-2084
39. FORLINO A; WANG Q; MARINI JC
    COMBINED EFFECT OF A NULL ALLELE AND A NONCOLLAGENOUS INSERTION IN COL1A1 MESSENGER-RNA IS RESPONSIBLE FOR THE SEVERE PHENOTYPE IN A FAMILYAFFECTED BY OSTEOGENESIS IMPERFECTA
    Matrix biology
    
    A. Forlino et al., "COMBINED EFFECT OF A NULL ALLELE AND A NONCOLLAGENOUS INSERTION IN COL1A1 MESSENGER-RNA IS RESPONSIBLE FOR THE SEVERE PHENOTYPE IN A FAMILYAFFECTED BY OSTEOGENESIS IMPERFECTA", Matrix biology, 15(3), 1996, pp. 176-177
40. GRASSI G; MARINI JC
    HAMMERHEAD RIBOZYMES ACHIEVE ALLELE-SPECIFIC CLEAVAGE OF COLLAGEN MESSENGER-RNA IN-VITRO FROM PATIENTS AFFECTED BY OSTEOGENESIS IMPERFECT
    Matrix biology
    
    G. Grassi e J.C. Marini, "HAMMERHEAD RIBOZYMES ACHIEVE ALLELE-SPECIFIC CLEAVAGE OF COLLAGEN MESSENGER-RNA IN-VITRO FROM PATIENTS AFFECTED BY OSTEOGENESIS IMPERFECT", Matrix biology, 15(3), 1996, pp. 176-176
41. FORLINO A; MARINI JC
    UNUSUAL ELECTROPHORETIC MOBILITY OF ALPHA-2(I) COLLAGEN CHAIN CAUSED BY A GLY421 TO ASP SUBSTITUTION IN A LETHAL CASE OF OSTEOGENESIS IMPERFECTA
    Matrix biology
    
    A. Forlino e J.C. Marini, "UNUSUAL ELECTROPHORETIC MOBILITY OF ALPHA-2(I) COLLAGEN CHAIN CAUSED BY A GLY421 TO ASP SUBSTITUTION IN A LETHAL CASE OF OSTEOGENESIS IMPERFECTA", Matrix biology, 15(3), 1996, pp. 177-177
42. COHEN IR; GAJKO A; MARINI JC
    EXPRESSION AND REGULATION OF TYPE-I COLLAGEN AND OTHER MATRIX COMPONENTS IN OSTEOGENESIS IMPERFECTA OSTEOBLASTS
    Matrix biology
    
    I.R. Cohen et al., "EXPRESSION AND REGULATION OF TYPE-I COLLAGEN AND OTHER MATRIX COMPONENTS IN OSTEOGENESIS IMPERFECTA OSTEOBLASTS", Matrix biology, 15(3), 1996, pp. 177-178
43. COHEN IR; GAJKO A; MARINI JC
    EXPRESSION AND REGULATION OF TYPE-I COLLAGEN AND OTHER MATRIX COMPONENTS IN OSTEOGENESIS IMPERFECTA OSTEOBLASTS
    Journal of bone and mineral research
    
    I.R. Cohen et al., "EXPRESSION AND REGULATION OF TYPE-I COLLAGEN AND OTHER MATRIX COMPONENTS IN OSTEOGENESIS IMPERFECTA OSTEOBLASTS", Journal of bone and mineral research, 11, 1996, pp. 644-644
44. GRASSI G; MARINI JC
    RIBOZYMES - STRUCTURE, FUNCTION AND POTENTIAL THERAPY FOR DOMINANT GENETIC-DISORDERS
    Annals of medicine
    
    G. Grassi e J.C. Marini, "RIBOZYMES - STRUCTURE, FUNCTION AND POTENTIAL THERAPY FOR DOMINANT GENETIC-DISORDERS", Annals of medicine, 28(6), 1996, pp. 499-510
45. FORLINO A; WANG Q; MARINI JC
    ALTERNATIVE SPLICING CAUSED BY A LARGE DELETION IN COL1A1 GENE IS RESPONSIBLE FOR A SEVERE CASE OF OSTEOGENESIS IMPERFECTA TYPE-III
    Pediatric research
    
    A. Forlino et al., "ALTERNATIVE SPLICING CAUSED BY A LARGE DELETION IN COL1A1 GENE IS RESPONSIBLE FOR A SEVERE CASE OF OSTEOGENESIS IMPERFECTA TYPE-III", Pediatric research, 39(4), 1996, pp. 853-853
46. GRASSI G; MARINI JC
    HAMMERHEAD RIBOZYMES ACHIEVE ALLELE-SPECIFIC CLEAVAGE OF COLLAGEN MESSENGER-RNA IN-VITRO FROM PATIENTS AFFECTED BY OSTEOGENESIS IMPERFECTA
    Pediatric research
    
    G. Grassi e J.C. Marini, "HAMMERHEAD RIBOZYMES ACHIEVE ALLELE-SPECIFIC CLEAVAGE OF COLLAGEN MESSENGER-RNA IN-VITRO FROM PATIENTS AFFECTED BY OSTEOGENESIS IMPERFECTA", Pediatric research, 39(4), 1996, pp. 857-857
47. MARINI JC; JAMESON BA; LUBLIN FD; KORNGOLD R
    A CD4-CDR3 PEPTIDE ANALOG INHIBITS BOTH PRIMARY AND SECONDARY AUTOREACTIVE CD4(-CELL RESPONSES IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS()T)
    The Journal of immunology
    
    J.C. Marini et al., "A CD4-CDR3 PEPTIDE ANALOG INHIBITS BOTH PRIMARY AND SECONDARY AUTOREACTIVE CD4(-CELL RESPONSES IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS()T)", The Journal of immunology, 157(8), 1996, pp. 3706-3715
48. WANG Q; MARINI JC
    ANTISENSE OLIGODEOXYNUCLEOTIDES SELECTIVELY SUPPRESS EXPRESSION OF THE MUTANT ALPHA-2(I) COLLAGEN ALLELE IN TYPE-IV OSTEOGENESIS IMPERFECTAFIBROBLASTS - A MOLECULAR APPROACH TO THERAPEUTICS OF DOMINANT-NEGATIVE DISORDERS
    The Journal of clinical investigation
    
    Q. Wang e J.C. Marini, "ANTISENSE OLIGODEOXYNUCLEOTIDES SELECTIVELY SUPPRESS EXPRESSION OF THE MUTANT ALPHA-2(I) COLLAGEN ALLELE IN TYPE-IV OSTEOGENESIS IMPERFECTAFIBROBLASTS - A MOLECULAR APPROACH TO THERAPEUTICS OF DOMINANT-NEGATIVE DISORDERS", The Journal of clinical investigation, 97(2), 1996, pp. 448-454
49. WANG Q; FORLINO A; MARINI JC
    ALTERNATIVE SPLICING IN COL1A1 MESSENGER-RNA LEADS TO A PARTIAL NULL ALLELE AND 2 IN-FRAME FORMS WITH STRUCTURAL DEFECTS IN NONLETHAL OSTEOGENESIS IMPERFECTA
    The Journal of biological chemistry
    
    Q. Wang et al., "ALTERNATIVE SPLICING IN COL1A1 MESSENGER-RNA LEADS TO A PARTIAL NULL ALLELE AND 2 IN-FRAME FORMS WITH STRUCTURAL DEFECTS IN NONLETHAL OSTEOGENESIS IMPERFECTA", The Journal of biological chemistry, 271(45), 1996, pp. 28617-28623
50. TOWNSEND RM; BRIGGS C; MARINI JC; MURPHY GF; KORNGOLD R
    INHIBITORY EFFECT OF A CD4-CDR3 PEPTIDE ANALOG ON GRAFT-VERSUS-HOST DISEASE ACROSS A MAJOR HISTOCOMPATIBILITY COMPLEX-HAPLOIDENTICAL BARRIER
    Blood
    
    R.M. Townsend et al., "INHIBITORY EFFECT OF A CD4-CDR3 PEPTIDE ANALOG ON GRAFT-VERSUS-HOST DISEASE ACROSS A MAJOR HISTOCOMPATIBILITY COMPLEX-HAPLOIDENTICAL BARRIER", Blood, 88(8), 1996, pp. 3038-3047
51. GOANS RE; ABRAMS SA; VIEIRA NE; MARINI JC; PEREZ MD; YERGEY AL
    A 3-HOUR MEASUREMENT TO EVALUATE BONE CALCIUM TURNOVER
    Bone
    
    R.E. Goans et al., "A 3-HOUR MEASUREMENT TO EVALUATE BONE CALCIUM TURNOVER", Bone, 16(1), 1995, pp. 33-38
52. MARINI JC; JAMESON BA; KORNGOLD R
    STRUCTURE-BASED DESIGNED CD4 ANALOG INHIBITS EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE)
    The FASEB journal
    
    J.C. Marini et al., "STRUCTURE-BASED DESIGNED CD4 ANALOG INHIBITS EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE)", The FASEB journal, 9(4), 1995, pp. 784-784
53. COSTELLO JF; DINTELMANN R; FORMAN K; GILSTER JE; GREENWELL SR; GREGORY JF; HART J; HAZZARD FC; HEBERER RED; KLINGELHOEFER CM; LITTLETON PA; MARKARIAN JR; MULRYAN Y; REICHERT TJ; REUTER GC; RICHTER MK; SCHUERMANN J; ESTERLY NB; FARRINGTON FH; GUCKES AD; HOWARD RO; JORGENSON RJ; MARINI JC; MEYER CM; ROSSER LL; SYBERT VP; TANNER B
    GASTROINTESTINAL COMPLAINTS IN INDIVIDUALS WITH HYPOHIDROTIC ECTODERMAL DYSPLASIA (CHRIST-SIEMENS-TOURAINE SYNDROME)
    Pediatric dermatology
    
    J.F. Costello et al., "GASTROINTESTINAL COMPLAINTS IN INDIVIDUALS WITH HYPOHIDROTIC ECTODERMAL DYSPLASIA (CHRIST-SIEMENS-TOURAINE SYNDROME)", Pediatric dermatology, 12(3), 1995, pp. 288-289
54. MARINI JC; WANG Q
    ANTISENSE OLIGONUCLEOTIDES SELECTIVELY SUPPRESS PRODUCTION OF MUTANT ALPHA-2(I) COLLAGEN IN OSTEOGENESIS IMPERFECTA TYPE-IV FIBROBLASTS - AN APPROACH TO GENE-THERAPY FOR A DOMINANT DISORDER OF MATRIX STRUCTURAL PROTEIN
    Pediatric research
    
    J.C. Marini e Q. Wang, "ANTISENSE OLIGONUCLEOTIDES SELECTIVELY SUPPRESS PRODUCTION OF MUTANT ALPHA-2(I) COLLAGEN IN OSTEOGENESIS IMPERFECTA TYPE-IV FIBROBLASTS - AN APPROACH TO GENE-THERAPY FOR A DOMINANT DISORDER OF MATRIX STRUCTURAL PROTEIN", Pediatric research, 37(4), 1995, pp. 150-150
55. SARAFOVA AP; MARINI JC
    CULTURED OSTEOBLASTS FROM OSTEOGENESIS IMPERFECTA PATIENTS SYNTHESIZECOLLAGEN WHICH IS ELECTROPHORETICALLY DISTINCT FROM PATIENTS FIBROBLAST COLLAGEN
    Pediatric research
    
    A.P. Sarafova e J.C. Marini, "CULTURED OSTEOBLASTS FROM OSTEOGENESIS IMPERFECTA PATIENTS SYNTHESIZECOLLAGEN WHICH IS ELECTROPHORETICALLY DISTINCT FROM PATIENTS FIBROBLAST COLLAGEN", Pediatric research, 37(4), 1995, pp. 152-152
56. WANG Q; LEWIS MB; MARINI JC
    A NOVEL DELETION INSERTION MUTATION IN THE MESSENGER-RNA TRANSCRIBED FROM ONE ALPHA-1(I) COLLAGEN ALLELE IN FAMILY WITH DOMINANT TYPE-III OI AND GERMLINE MOSAICISM
    Pediatric research
    
    Q. Wang et al., "A NOVEL DELETION INSERTION MUTATION IN THE MESSENGER-RNA TRANSCRIBED FROM ONE ALPHA-1(I) COLLAGEN ALLELE IN FAMILY WITH DOMINANT TYPE-III OI AND GERMLINE MOSAICISM", Pediatric research, 37(4), 1995, pp. 155-155
57. TOWNSEND RM; MARINI JC; KORNGOLD R
    INHIBITORY, EFFECT OF A CD4-CDR3 PEPTIDE ANALOG GRAFT-VS-HOST DISEASEFOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    Blood
    
    R.M. Townsend et al., "INHIBITORY, EFFECT OF A CD4-CDR3 PEPTIDE ANALOG GRAFT-VS-HOST DISEASEFOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION", Blood, 86(10), 1995, pp. 2480-2480
58. WANG Q; MARINI JC
    SELECTIVE IN-VITRO RIBOZYME CLEAVAGE OF MUTANT AND NORMAL TYPE-I COLLAGEN RNA FROM A CASE OF TYPE-III OSTEOGENESIS IMPERFECTS
    American journal of human genetics
    
    Q. Wang e J.C. Marini, "SELECTIVE IN-VITRO RIBOZYME CLEAVAGE OF MUTANT AND NORMAL TYPE-I COLLAGEN RNA FROM A CASE OF TYPE-III OSTEOGENESIS IMPERFECTS", American journal of human genetics, 57(4), 1995, pp. 1470-1470
59. MARINI JC; STEBE B; KARTHEUSER E
    EXCITON-PHONON INTERACTION IN CDSE AND CUCL POLAR SEMICONDUCTOR NANOSPHERES
    Physical review. B, Condensed matter
    
    J.C. Marini et al., "EXCITON-PHONON INTERACTION IN CDSE AND CUCL POLAR SEMICONDUCTOR NANOSPHERES", Physical review. B, Condensed matter, 50(19), 1994, pp. 14302-14308
60. MARINI JC; WANG Q
    USE OF ANTISENSE OLIGONUCLEOTIDES TO SELECTIVELY SUPPRESS PRODUCTION OF THE MUTANT ALPHA-2(I) CHAIN IN OSTEOGENESIS IMPERFECTA TYPE-IV FIBROBLASTS
    Pediatric research
    
    J.C. Marini e Q. Wang, "USE OF ANTISENSE OLIGONUCLEOTIDES TO SELECTIVELY SUPPRESS PRODUCTION OF THE MUTANT ALPHA-2(I) CHAIN IN OSTEOGENESIS IMPERFECTA TYPE-IV FIBROBLASTS", Pediatric research, 35(4), 1994, pp. 10000153-10000153
61. JAMESON BA; MCDONNELL JM; MARINI JC; KORNGOLD R
    A RATIONALLY DESIGNED CD4 ANALOG INHIBITS EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
    Nature
    
    B.A. Jameson et al., "A RATIONALLY DESIGNED CD4 ANALOG INHIBITS EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS", Nature, 368(6473), 1994, pp. 744-746
62. FILIE JD; ORRISON BM; WANG Q; LEWIS MB; MARINI JC
    A DE-NOVO G-]A MUTATION AT THE ALPHA-2(I) EXON 16 SPLICE DONOR SITE CAUSES SKIPPING OF EXON 16 IN THE CDNA OF ONE ALLELE OF AN OI TYPE-IV PROBAND(1)
    Human mutation
    
    J.D. Filie et al., "A DE-NOVO G-]A MUTATION AT THE ALPHA-2(I) EXON 16 SPLICE DONOR SITE CAUSES SKIPPING OF EXON 16 IN THE CDNA OF ONE ALLELE OF AN OI TYPE-IV PROBAND(1)", Human mutation, 2(5), 1993, pp. 380-388
63. MARINI JC; STEBE B; KARTHEUSER E
    INFLUENCE OF THE ELECTRON-PHONON INTERACTION ON A DONOR LIKE EXCITON IN A SEMICONDUCTOR MICROSPHERE
    Solid state communications
    
    J.C. Marini et al., "INFLUENCE OF THE ELECTRON-PHONON INTERACTION ON A DONOR LIKE EXCITON IN A SEMICONDUCTOR MICROSPHERE", Solid state communications, 87(5), 1993, pp. 435-437
64. CHARNAS LR; MARINI JC
    COMMUNICATING HYDROCEPHALUS, BASILAR INVAGINATION, AND OTHER NEUROLOGIC FEATURES IN OSTEOGENESIS IMPERFECTA
    Neurology
    
    L.R. Charnas e J.C. Marini, "COMMUNICATING HYDROCEPHALUS, BASILAR INVAGINATION, AND OTHER NEUROLOGIC FEATURES IN OSTEOGENESIS IMPERFECTA", Neurology, 43(12), 1993, pp. 2603-2608
65. MARINI JC; BORDENICK S; HEAVNER G; ROSE S; HINTZ R; ROSENFELD R; CHROUSOS GP
    THE GROWTH-HORMONE AND SOMATOMEDIN AXIS IN SHORT CHILDREN WITH OSTEOGENESIS IMPERFECTA
    The Journal of clinical endocrinology and metabolism
    
    J.C. Marini et al., "THE GROWTH-HORMONE AND SOMATOMEDIN AXIS IN SHORT CHILDREN WITH OSTEOGENESIS IMPERFECTA", The Journal of clinical endocrinology and metabolism, 76(1), 1993, pp. 251-256
66. WANG Q; ORRISON BM; MARINI JC
    2 ADDITIONAL CASES OF OSTEOGENESIS IMPERFECTA WITH SUBSTITUTIONS FOR GLYCINE IN THE ALPHA-2(I) COLLAGEN CHAIN - A REGIONAL MODEL RELATING MUTATION LOCATION WITH PHENOTYPE
    The Journal of biological chemistry
    
    Q. Wang et al., "2 ADDITIONAL CASES OF OSTEOGENESIS IMPERFECTA WITH SUBSTITUTIONS FOR GLYCINE IN THE ALPHA-2(I) COLLAGEN CHAIN - A REGIONAL MODEL RELATING MUTATION LOCATION WITH PHENOTYPE", The Journal of biological chemistry, 268(33), 1993, pp. 25162-25167
67. MARINI JC; WANG Q; LEWIS MB
    IDENTIFICATION OF AN IDENTICAL NON-LETHAL-ALPHA-1(I) MUTATION IN 2 UNRELATED FAMILIES WITH WIDE VARIABILITY OF OSTEOGENESIS IMPERFECTA PHENOTYPE
    American journal of human genetics
    
    J.C. Marini et al., "IDENTIFICATION OF AN IDENTICAL NON-LETHAL-ALPHA-1(I) MUTATION IN 2 UNRELATED FAMILIES WITH WIDE VARIABILITY OF OSTEOGENESIS IMPERFECTA PHENOTYPE", American journal of human genetics, 53(3), 1993, pp. 1199-1199
68. WANG Q; MARINI JC
    USE OF ANTISENSE OLIGONUCLEOTIDES DIRECTED AT MESSENGER-RNA AND GENOMIC DNA TO SELECTIVELY SUPPRESS PRODUCTION OF THE MUTANT ALPHA-2(I) CHAIN IN OSTEOGENESIS IMPERFECTA TYPE-IV FIBROBLASTS
    American journal of human genetics
    
    Q. Wang e J.C. Marini, "USE OF ANTISENSE OLIGONUCLEOTIDES DIRECTED AT MESSENGER-RNA AND GENOMIC DNA TO SELECTIVELY SUPPRESS PRODUCTION OF THE MUTANT ALPHA-2(I) CHAIN IN OSTEOGENESIS IMPERFECTA TYPE-IV FIBROBLASTS", American journal of human genetics, 53(3), 1993, pp. 1251-1251